• ALLG Scientific Meeting – May 2025

    Shnagri-la Hotel Sydney, NSW, Australia

    ALLG's Scientific Meetings are important events for member clinicians and researchers to come together to progress blood cancer clinical [...]

  • Heart Failure 2025

    Belgrde and Online , Serbia

    The Heart Failure Congress stands as the premier global gathering encompassing the full spectrum of heart failure.

  • QCSANZ Case Series May 2025

    Royal Brisbane and Women’s Hospital Princess Alexandra Hospital Brisbane, QLD, Australia

    Queensland Cardiology Advanced Trainee Case Series” presentations In depth Presentations of Case History and Outcomes Royal Brisbane and Women’s Hospital Princess Alexandra Hospital

  • 73rd Annual Scientific Meeting of CSANZ

    The 73rd Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand and 49th Annual Scientific Meeting of the International Society for Heart Research (Australasian Section), will be held at the Brisbane Convention and Exhibition Centre from 14 - 17 August 2025.

  • HSANZ VIC Branch – September Meeting

    Leonda by the Yarra 2 Wallen Road, Hawthorn, VIC, Australia

    HSANZ invites members and guests to attend our VIC Inter-Hospital Meeting. 6:30pm Arrival • 7.00pm Presentations • 9.00pm Conclusion What's new in AL amyloidosis and ATTR? Is a cure on the horizon?

    $25
  • Oceanic Palliative Care Conference 2025

    The Brisbane Convention and Exhibition Centre Glenelg St, South Brisbane, QLD, Australia

    The Oceanic Palliative Care Conference (OPCC)is one of the biggest, premier palliative care conference in the southern hemisphere. 

  • IKMG Seventh International Meeting

    Lisbon, Portugal Lisbon, Portugal

    We are pleased to announce the 7th International Kidney and Monoclonal Gammopathies Meeting, taking place on 26–27 September 2025 in Lisbon, Portugal.

  • 2025 Amyloidosis Research Consortium

    FDA White Oak Campus 10903 New Hampshire Avenue, Silver Spring, MD, United States

    Participants including clinicians, researchers, FDA and global health authorities, industry partners, patients, and the Amyloidosis Research Consortium (ARC) will detail the Amyloidosis Forum stakeholder working groups’ projects to accelerate drug development in AL and ATTR Amyloidosis.

  • 2026-2027 Amyloidosis Fellowship Program

    virtual

    The International Society of Amyloidosis (ISA) is pleased to announce that applications are now open for the 2026-2027 Amyloidosis Fellowship [...]

  • Haematologists & ATTR Amyloid: Not All Amyloid is AL – Free online masterclass

    Virtual event

    This focused 90-minute session will examine diagnostic pitfalls, real-world challenges, and practical approaches to getting the diagnosis right - the first time. Through multidisciplinary perspectives and case-based discussion, the program will unpack when to suspect ATTR, how to interpret red flag features, and the evolving role of the haematologist in ATTR pathways.

    FREE